On-Sale Bar Debated In Oral Arguments Before Supreme Court
WASHINGTON, D.C. — Counsel for the owner of a patented drug for reducing nausea in cancer patients undergoing chemotherapy told the U.S. Supreme Court on Dec. 4 that its private licensing...To view the full article, register now.
Already a subscriber? Click here to view full article